Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay by Robles Pérez, D. et al.
Robles-Pérez et al. BMC Veterinary Research  (2015) 11:226 
DOI 10.1186/s12917-015-0543-1RESEARCH ARTICLE Open AccessScreening anthelmintic resistance to
triclabendazole in Fasciola hepatica isolated
from sheep by means of an egg hatch assay
David Robles-Pérez1, José Manuel Martínez-Pérez1, Francisco Antonio Rojo-Vázquez1,2
and María Martínez-Valladares2*Abstract
Background: In the present study, the detection of anthelmintic resistance to triclabendazole (TCBZ) in sheep
infected by Fasciola hepatica was studied using an egg hatch assay (EHA). F. hepatica eggs were recovered from
bile and faeces of infected animals by isolates with different grade of anthelmintic resistance to TCBZ: i) a resistant
isolate (RT); ii) a susceptible isolate (ST); iii) naturally infected sheep by a susceptible field strain (FST). In the EHA the
percentage of hatched eggs were calculated according to the following concentrations of TCBZ diluted in
dimethyl-sulfoxide (DMSO): 0.05, 0.2, 1, 5, and 25 μg/ml.
Results: In relation to the EHAs carried out with the eggs from bile of sheep infected by ST, differences were found
in the percentage of hatched eggs between the control well, only with DMSO, and the two highest concentrations
of TCBZ (5 and 25 μg/m) (p < 0.05). However, when we tested the drug with the eggs from the bile of sheep
infected by RT, the percentage of hatched eggs was similar among all concentrations. Since the range of hatching
varied between isolates, we calculated the ratio of the results of each concentration to its control value confirming
the higher hatching in RT than in ST.
We developed an EHA with eggs recovered from faeces in order to avoid the slaughter of sheep. The results of
the EHAs with the isolate ST showed differences in the percentage of hatching between the highest
concentration (25 μg/ml) and the control well (p < 0.05); however, these differences were not confirmed under
field conditions with the strain FST.
Conclusions: The ovicidal effect of TCBZ in F. hepatica eggs from bile was shown using a commercial formulation
diluted in DMSO with a minimum concentration of 5 μg/ml. However, in eggs recovered from faeces the results are
not conclusive. The cleaning of eggs recovered from faeces is an important issue that should be reviewed and
standardized before comparing results between susceptible and resistant isolates in this kind of EHA.
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Fasciola spp. infects mammals worldwide, mainly rumi-
nants, but also humans can become infected. In ruminants,
and especially in sheep, the infection reduces feed conver-
sion, growth, and meat and milk production. Moreover, it is
one of the major causes of liver condemnations at abattoirs
and interferes with fertility and fecundity [1].* Correspondence: mmarva@eae.csic.es
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this article, unless otherwise stated.The infection is usually caused, in temperate areas of
the world, by the common liver fluke F. hepatica. Its
prevalence is rising nowadays due to different factors
such as climate change, man-made environmental modi-
fications or the presence of anthelmintic resistance (AR)
[1, 2]. AR is the result of repeated administration of the
same anthelmintic; moreover, its development has been
favoured by ineffective treatment due to the underdos-
ing. AR is the result of repeated treatments of the same
anthelmintic although its development is also favoured
by the administration of underdosing or overdosing [3].article is distributed under the terms of the Creative Commons Attribution
mons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
you give appropriate credit to the original author(s) and the source,
ense, and indicate if changes were made. The Creative Commons Public
ommons.org/publicdomain/zero/1.0/) applies to the data made available in
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fasciolosis belongs to benzimidazole (BZ) family and is
the triclabendazole (TCBZ). TCBZ has been the drug of
choice for treating liver fluke infections in livestock
for over 20 years [4] since it is the only anthelmintic
effective against both F. hepatica stages, immature
and mature flukes [5]. However, there are several re-
ports describing resistant strains of F. hepatica to
TCBZ all around the world, in Australia [6], Argentina
[7] and also in different European countries [8–11].
Therefore, early detection of resistance is essential, since
reversion to susceptibility does not seem to occur [12].
Some in vivo and in vitro tests have been developed to
detect the AR in ruminants. Among the in vivo tests, the
faecal egg count reduction test (FECRT) is based on the
reduction of the number of eggs in faeces after the
anthelmintic treatment [13]. Regarding in vitro tests, an
egg hatch assay (EHA) has been described to detect BZ
resistance in Trichostrongylidae [14, 15]. The EHA is
based on the ovicidal properties of some BZs, and on the
capacity of eggs from resistant isolates to embrionate and
hatch at higher concentrations than those ones from a sus-
ceptible isolate [16]. Although the EHA was originally
designed to detect AR in gastrointestinal nematodes (GIN),
some studies have been carried out with F. hepatica eggs
from gall bladder and/or faeces using TCBZ, albendazole
(ABZ) and their sulphoxide metabolites [17–19].
The aim of this study has been to characterize the
susceptibility and resistance of F. hepatica isolates to
TCBZ by means of an EHA using eggs from gall bladder
and faeces.Methods
Isolates of F. hepatica
Eight experimentally infected sheep with two F. hepat-
ica isolates having different levels of resistance or sus-
ceptibility to TBCZ were used. The susceptible isolate
to TCBZ (ST) was the Shrewsbury/South Gloucester
isolate (Ridgeway Research Ltd Company, UK); the
TCBZ-susceptibility of this isolate was confirmed in a
clinical trial by Martínez-Valladares et al. [11]. The
resistant isolate to TCBZ (RT) was characterized by
Álvarez-Sánchez et al. [10] in a flock located in the
Spanish province of León; the egg reduction in this
flock after the treatment of sheep with TCBZ was
81.8 % on 16 day after treatment and 75.7 % on 30 day
after treatment. The molecular characterization of RT
was recently described by Martínez-Valladares and
Rojo-Vázquez [20].
On the other hand, naturally infected sheep with a
TCBZ-susceptible field strain (FST) situated in Palencia,
Spain, was also tested. The susceptibility of this strain was
previously shown by Robles-Pérez et al. [21].Egg hatch assays
A commercial formulation of TCBZ (Fasinex®) diluted in
dimethyl sulfoxide (DMSO) was used to carry out the
EHAs. The concentration of TCBZ in this commercial
formulation was 50 mg/ml. Dilutions of 10, 40, 200,
1000 and 5000 μg/ml were prepared to obtain a final
concentration in the wells of 0.05, 0.2, 1, 5, and 25 μg/
ml after adding 10 μl of each dilution to a total volume
of 2 ml. In all EHAs, control wells with 10 μl of DMSO
were included.
Eggs from faeces were obtained by sedimentation [22]
from animals infected by ST and from a pool of faeces of
sheep naturally infected by FST. Four sheep, two infected
with ST and two with RT, were killed by injection of
sodium pentobarbital (Dolethal®) into the jugular vein in
order to recover eggs from the bile. F. hepatica eggs were
directly recovered from the gall bladder and washed sev-
eral times with tap water by sedimentation. The slaughter
of animals complies with national regulations (R.D. 53/
2013) and with all animal welfare standards, taking ac-
count all necessary moral and ethical issues in the use of
experimental animals.
For the EHA, a 24 well cell culture plate was used and
all anthelmintic concentrations were tested in duplicate.
Into each well, 1890 μl of water, 100 μl of water with
30–50 eggs, and 10 μl of each dilution were placed. Two
control wells containing 10 μl of DMSO, without TCBZ,
were also included. Plates were incubated for 14 days at
25 °C in darkness. They were then placed under light for
2 h to stimulate hatching of the miracidia. The number
of eggs hatched, embryonated, and unembryonated were
counted. All EHA assays were repeated five times for
each isolate.
Data and statistical analysis
The percentage of hatched eggs was calculated for each
isolate, using the following formula:
Percentage of hatching ¼ ðnumber of hatched eggs =
total number of eggsÞ  100
The number of eggs is the sum of hatched, embryonated,
and unembryonated eggs (egg in morula stage, without
miracidium). The results reported in this study are the
mean of five repetitions of each EHA.
With the aim to compare two EHAs with different
hatch ranges, a ratio of the results of each concentration
to the control was calculated, using the following formula:
Ratio ¼ ð% hatching of each concentration =
% hatching of controlÞ  100
The data were analyzed using the statistical computer
package for social sciences SPSS. A one-way ANOVA was
used to assess differences. The Dunnett test was carried out
to confirm significant differences between concentrations
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Fig. 2 Ratio of hatched eggs from bile. The ratio for each
concentration to its corresponding control for the susceptible and
resistant isolates was showedResults
EHA with eggs from bile
In the EHAs carried out with the eggs from bile, we
compared two isolates, one susceptible (ST) and an-
other resistant (RT) to TCBZ (Fig. 1).
The percentages of hatching in ST isolate are shown
in Fig. 1a. The results show that the lower the concen-
tration of the drug is, the higher the percentage of
hatched eggs, ranging from 43 to 53 %, with a value of
63 % in the control well. The differences between the
two highest concentrations (5 and 25 μg/ml) and the
control were significant (p < 0.05). On the other hand,
the percentage of hatched eggs in RT ranged from 19 to
21 %, being 22 % in the control well (Fig. 1b). In this
isolate, no significant differences were shown between
concentrations.
After calculating the ratio of the results of each con-
centration to its control value, in both isolates (Fig. 2),
we confirmed the higher hatching in RT than in ST.EHA with eggs from faeces
Figure 3 shows the results of percentage of hatched eggs in
the susceptible isolates. The hatching percentage ranged
from 17 to 23 %, with a control value of 26 % for ST.
Significant differences were observed between the highest
concentration (25 μg/ml) and the control well (p < 0.05)
(Fig. 3a).
Using a field strain, FST, also susceptible to TCBZ
(Fig. 3b), the percentages of hatching were similar be-
tween concentrations, ranging from 19 to 29 %, beingFig. 1 Percentages of hatched eggs in susceptible and resistant isolates us
(susceptible to TCBZ) (a) and RT (resistant to TCBZ) (b) were showed. Signi
*(p < 0.05)33 % in the control well; no significant differences were
shown between concentrations.
Discussion
The study of AR to BZs in ruminants infected by hel-
minth parasites is an important issue to avoid its
development and spread. Several authors have used
the in vitro technique EHA in order to characterize
strains of GIN and F. hepatica in sheep flocks [3, 14,
17–19, 23]. In the present study, the EHA has been
adapted and modified to detect the AR to TCBZ in
sheep infected by F. hepatica.
TCBZ metabolism includes ruminal and hepatic biotrans-
formations in metabolites as TCBZ-sulphoxide, TCBZ-
sulphone, hydroxy-TCBZ, hydroxy-TCBZSO and hydroxy-
TCBZSO2 [24]. The TCBZ and its sulphoxide and sulphone
metabolites contribute to anthelmintic activity and varia-
tions in the regional specificity in the levels of disruption to
the tegument of the fluke are presents [25]. The drug anding eggs from bile. The percentages of hatched eggs in the isolates ST
ficant difference between concentration and control is indicated by
Fig. 3 Percentage of hatched eggs in susceptible isolates using eggs from faeces. The percentages of hatched eggs in the isolates ST
(susceptible to TCBZ) (a) and FST (field susceptible strain to TCBZ) (b) were showed. Significant difference between concentration and control is
indicated by *(p < 0.05)
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polymerization to form microtubules in the fluke [26]. Ac-
cordingly, the integrity of the surface membrane of the
parasite is altered leading to damage to the integument and
causing the death of the fluke [4].
Firstly, we carried out an EHA using a commercial for-
mulation, Fasinex®, and eggs from bile. Both, TCBZ and
its sulfoxide metabolite were used by Álvarez et al. [17]
in a preliminary study testing two formulations of TCBZ
in eggs from bile, one diluted with methanol and an-
other one with DMSO. These authors showed a range of
hatching of 45–80 % using concentrations of TCBZ
between 5 and 20 nmol/ml, equivalent to 1.8–7.2 μg/ml;
however, they did not find any ovicidal effect of TCBZ
in egss from susceptible and resistant strains to this
drug. Due to this fact, in the current study we extended
the range of concentrations to test the efficacy of TCBZ
in eggs from bile, between 0.05 and 25 μg/ml. After
comparing the percentages of hatching between the sus-
ceptible (ST) and resistant (RT) isolates, we found only
significant differences between the control and the two
highest concentrations (5 and 25 μg/ml) in ST (p < 0.05),
suggesting an ovicidal effect of the drug in this case.
However, when the EHA was carried out with eggs from
RT, no differences were found among concentrations
(Fig. 1b). Recently, Fairweather et al. [18] tested a 60 μg/
ml concentration of the sulfoxide metabolite of TCBZ in
the same RT isolate that we used in the current study.
This author found a very low level of hatching in RT
(<2 %) and therefore they classified the isolate as sus-
ceptible. In the present study we showed a percentage
of hatching of 20.5 % after testing the highest concen-
tration (25 μg/ml); moreover, no significant differences
were described between any concentration and the
control using the same RT isolate. The reason of these
different results in relation to resistance of RT couldbe due to the different formulations of TCBZ. Unlike
our EHAs, Fairweather et al. [18] used a higher con-
centration and the sulphoxide metabolite of the drug,
not the pure TCBZ.
With the aim to compare the results described be-
tween the susceptible and resistant isolates, we calcu-
lated a ratio for each isolate and concentration, since
the hatching ranges of both isolates were different,
probably due to the variability of the technique or the
quality of eggs recovered (Fig. 2). The ratios show that
the hatching was higher in RT, confirming its higher
level of resistance.
On the other hand, with the purpose to avoid the
slaughter of sheep to detect the AR using in vitro tech-
niques, we developed an EHA with eggs of F. hepatica
collected from faeces. With the aim to determine the
repeatability of this technique using eggs from faeces, we
only tested susceptible isolates, ST and FST. In this case,
we observed that the hatching ranges were similar
between each other (Fig. 3a and b), however, we only
showed significant differences between the highest con-
centration (25 μg/ml) and the control well in ST. This
finding was not confirmed in FST. It is important to
note that the percentages of hatching in ST were lower
than those obtained in the EHA using eggs from bile.
The reason of the low hatching rates could be the
presence of rest of faeces or impurities. Indeed,
according to Rowcliffe and Ollerenshaw, [27] one of
the critical factors for hatching is that the eggs must
have become freed from the faeces. Robles-Pérez et al.
[19] carried out EHAs to detect the resistance to ABZ
using F. hepatica eggs recovered from faeces. In that
case the percentages of hatching in the control wells
were 33, 57 and 71 % for a susceptible strain and 49 %
for a resistant strain. Therefore, there is a great variabil-
ity in the hatching rates. It seems that the methodology to
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EHA, therefore, this step needs more review and
standardization before comparing results between sus-
ceptible and resistant isolates.
Conclusions
The ovicidal effect of TCBZ in F. hepatica eggs from bile
was shown using a commercial formulation diluted in
DMSO with a minimum concentration of 5 μg/ml. We
compared the hatching rates of two isolates, one suscep-
tible and another resistant to TCBZ, and we only found
significant differences between the two highest concen-
trations (5 and 25 μg/ml) and the control well in the
susceptible isolate. However, in eggs recovered from
faeces the results are not conclusive. Significant differ-
ences were shown in the percentages of hatching
between the highest concentration (25 μg/ml) and the
control in a susceptible isolate, but these results were
not confirmed under field conditions with another sus-
ceptible strain.
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